Flinders University Flinders Academic Commons
 

Flinders Academic Commons >
Research Publications >
ERA 2010 >
07 - Biomedical and Clinical Research >
1112 - Oncology and Carcinogenesis >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2328/11137

Title: Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia
Authors: Waters, K
Webster, Boyd
Zhu, L
Sykes, Pamela Joy
Morley, Alexander Alan
Brisco, Michael
Chengyuan, X
Dalla Pozza, L
Ferrara, D
Haber, M
Kwan, E
Marshall, G M
Norris, M D
Issue Date: 2003
Citation: Marshall, G.M., Haber, M., Kwan, E., Zhu, L., Ferrara, D., Chengyuan, X., Brisco, M., Sykes, P.J., Morley, A.A., Webster, et al., 2003. Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 21(4), 704-709.
URI: http://hdl.handle.net/2328/11137
ISSN: 0732-183X
Appears in Collections:1112 - Oncology and Carcinogenesis

Files in This Item:

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback